469 related articles for article (PubMed ID: 21543211)
21. The fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms improves insulin resistance and hepatic lipid accumulation by modulation of liver adenosine monophosphate-activated protein kinase activity and lipogenic gene expression in high-fat diet-fed obese mice.
Saito T; Nishida M; Saito M; Tanabe A; Eitsuka T; Yuan SH; Ikekawa N; Nishida H
Nutr Res; 2016 Oct; 36(10):1090-1097. PubMed ID: 27865350
[TBL] [Abstract][Full Text] [Related]
22. Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet.
Wu Y; Wu T; Wu J; Zhao L; Li Q; Varghese Z; Moorhead JF; Powis SH; Chen Y; Ruan XZ
J Endocrinol; 2013 Dec; 219(3):195-204. PubMed ID: 24029730
[TBL] [Abstract][Full Text] [Related]
23. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
24. Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling.
Ellacott KL; Murphy JG; Marks DL; Cone RD
Endocrinology; 2007 Dec; 148(12):6186-94. PubMed ID: 17901224
[TBL] [Abstract][Full Text] [Related]
25. Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice.
Allen L; Ramalingam L; Menikdiwela K; Scoggin S; Shen CL; Tomison MD; Kaur G; Dufour JM; Chung E; Kalupahana NS; Moustaid-Moussa N
J Nutr Biochem; 2017 Oct; 48():128-137. PubMed ID: 28825992
[TBL] [Abstract][Full Text] [Related]
26. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
[TBL] [Abstract][Full Text] [Related]
27. Phlorizin Supplementation Attenuates Obesity, Inflammation, and Hyperglycemia in Diet-Induced Obese Mice Fed a High-Fat Diet.
Shin SK; Cho SJ; Jung UJ; Ryu R; Choi MS
Nutrients; 2016 Feb; 8(2):92. PubMed ID: 26891322
[TBL] [Abstract][Full Text] [Related]
28. Melinjo (Gnetum gnemon L.) seed extract induces uncoupling protein 1 expression in brown fat and protects mice against diet-induced obesity, inflammation, and insulin resistance.
Yoneshiro T; Kaede R; Nagaya K; Saito M; Aoyama J; Elfeky M; Okamatsu-Ogura Y; Kimura K; Terao A
Nutr Res; 2018 Oct; 58():17-25. PubMed ID: 30340811
[TBL] [Abstract][Full Text] [Related]
29. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
30. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
31. Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice.
Kwon EY; Choi MS
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862092
[TBL] [Abstract][Full Text] [Related]
32. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
[TBL] [Abstract][Full Text] [Related]
33. [Effects of bifid triple viable on chronic low-grade inflammation in obese mice induced by high fat diet].
Lu M; Yuan L; Hu N; Zhong X; Jiang Y; Lin M; Lu X
Wei Sheng Yan Jiu; 2022 Sep; 51(5):797-802. PubMed ID: 36222043
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice.
Inafuku M; Nagao K; Nomura S; Shirouchi B; Inoue N; Nagamori N; Nakayama H; Toda T; Yanagita T
Br J Nutr; 2012 Mar; 107(5):639-46. PubMed ID: 21787451
[TBL] [Abstract][Full Text] [Related]
35. Anti-diabetic effect of anthocyanin cyanidin-3-O-glucoside: data from insulin resistant hepatocyte and diabetic mouse.
Ye X; Chen W; Huang XF; Yan FJ; Deng SG; Zheng XD; Shan PF
Nutr Diabetes; 2024 Mar; 14(1):7. PubMed ID: 38429305
[TBL] [Abstract][Full Text] [Related]
36. Ursolic Acid Attenuates Hepatic Steatosis, Fibrosis, and Insulin Resistance by Modulating the Circadian Rhythm Pathway in Diet-Induced Obese Mice.
Kwon EY; Shin SK; Choi MS
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30423963
[TBL] [Abstract][Full Text] [Related]
37. High-fat Western diet-induced obesity contributes to increased tumor growth in mouse models of human colon cancer.
O'Neill AM; Burrington CM; Gillaspie EA; Lynch DT; Horsman MJ; Greene MW
Nutr Res; 2016 Dec; 36(12):1325-1334. PubMed ID: 27866828
[TBL] [Abstract][Full Text] [Related]
38. URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice.
Tanaka Y; Nagoshi T; Takahashi H; Oi Y; Yoshii A; Kimura H; Ito K; Kashiwagi Y; Tanaka TD; Yoshimura M
Mol Metab; 2022 Jan; 55():101411. PubMed ID: 34863940
[TBL] [Abstract][Full Text] [Related]
39. Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver.
Ashino NG; Saito KN; Souza FD; Nakutz FS; Roman EA; Velloso LA; Torsoni AS; Torsoni MA
J Nutr Biochem; 2012 Apr; 23(4):341-8. PubMed ID: 21543214
[TBL] [Abstract][Full Text] [Related]
40. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
